BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 15694201)

  • 1. Comparison of CNS and PNS myelin proteins in the pathology of myelin disorders.
    Quarles RH
    J Neurol Sci; 2005 Feb; 228(2):187-9. PubMed ID: 15694201
    [No Abstract]   [Full Text] [Related]  

  • 2. Peroxisomes, myelination, and axonal integrity in the CNS.
    Baes M; Aubourg P
    Neuroscientist; 2009 Aug; 15(4):367-79. PubMed ID: 19666893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The raft-associated protein MAL is required for maintenance of proper axon--glia interactions in the central nervous system.
    Schaeren-Wiemers N; Bonnet A; Erb M; Erne B; Bartsch U; Kern F; Mantei N; Sherman D; Suter U
    J Cell Biol; 2004 Aug; 166(5):731-42. PubMed ID: 15337780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular anatomy and genetics of myelin proteins in the peripheral nervous system.
    Snipes GJ; Suter U
    J Anat; 1995 Jun; 186 ( Pt 3)(Pt 3):483-94. PubMed ID: 7559122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelination and motor coordination are increased in transferrin transgenic mice.
    Saleh MC; Espinosa de los Monteros A; de Arriba Zerpa GA; Fontaine I; Piaud O; Djordjijevic D; Baroukh N; Garcia Otin AL; Ortiz E; Lewis S; Fiette L; Santambrogio P; Belzung C; Connor JR; de Vellis J; Pasquini JM; Zakin MM; Baron B; Guillou F
    J Neurosci Res; 2003 Jun; 72(5):587-94. PubMed ID: 12749023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins.
    Kuhlmann T; Wendling U; Nolte C; Zipp F; Maruschak B; Stadelmann C; Siebert H; Brück W
    J Neurosci Res; 2002 Jan; 67(2):185-90. PubMed ID: 11782962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.
    Garbern JY
    J Neurol Sci; 2005 Feb; 228(2):201-3. PubMed ID: 15694206
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential changes in axonal conduction following CNS demyelination in two mouse models.
    Bando Y; Takakusaki K; Ito S; Terayama R; Kashiwayanagi M; Yoshida S
    Eur J Neurosci; 2008 Nov; 28(9):1731-42. PubMed ID: 18973589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protein composition and structure of the myelin sheath. Part I].
    Pietrucha-Dutczak M; Marcol W; Korczyńska I; Matuszek I; Górka D; Lewin-Kowalik J
    Pol Merkur Lekarski; 2003 Sep; 15(87):268-72. PubMed ID: 14679855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.
    Yazawa I; Giasson BI; Sasaki R; Zhang B; Joyce S; Uryu K; Trojanowski JQ; Lee VM
    Neuron; 2005 Mar; 45(6):847-59. PubMed ID: 15797547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oligodendrocytes have a key role in the development of CNS function and in myelin related diseases].
    Anderson ES; Bjartmar C
    Lakartidningen; 2000 Jul; 97(28-29):3265-8. PubMed ID: 10997013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in the morphology of Wallerian degeneration in the central nervous system (CNS) and peripheral nervous system (PNS) and its effect on regeneration.
    Wisniewski HM
    Birth Defects Orig Artic Ser; 1983; 19(4):389-95. PubMed ID: 6871406
    [No Abstract]   [Full Text] [Related]  

  • 13. Why is Wallerian degeneration in the CNS so slow?
    Vargas ME; Barres BA
    Annu Rev Neurosci; 2007; 30():153-79. PubMed ID: 17506644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
    Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
    Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Zehr C; Lewis J; Hutton M; Yen SH; Dickson DW
    J Neurocytol; 2005 Dec; 34(6):397-410. PubMed ID: 16902761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin and axon pathology in a long-term study of PMP22-overexpressing mice.
    Verhamme C; King RH; ten Asbroek AL; Muddle JR; Nourallah M; Wolterman R; Baas F; van Schaik IN
    J Neuropathol Exp Neurol; 2011 May; 70(5):386-98. PubMed ID: 21487305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolipid protein is necessary in peripheral as well as central myelin.
    Garbern JY; Cambi F; Tang XM; Sima AA; Vallat JM; Bosch EP; Lewis R; Shy M; Sohi J; Kraft G; Chen KL; Joshi I; Leonard DG; Johnson W; Raskind W; Dlouhy SR; Pratt V; Hodes ME; Bird T; Kamholz J
    Neuron; 1997 Jul; 19(1):205-18. PubMed ID: 9247276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene.
    Edgar JM; McLaughlin M; Barrie JA; McCulloch MC; Garbern J; Griffiths IR
    Acta Neuropathol; 2004 Apr; 107(4):331-5. PubMed ID: 14745569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.